FDA clears Tandem Mobi durable automated insulin pump

Tandem Diabetes Care (Nasdaq:TNDM) announced today that the FDA cleared its Tandem Mobi automated insulin delivery system.

Drew Voytal (@DrewVoytal) / X

Loren Whyte MS, RD, CDCES, BC-ADM posted on LinkedIn

Holly Osborne on LinkedIn: #christmasmarket #communitydevelopment

Tandem Diabetes Care's New Tech Options

Heartland Endocrine Group

Naveed Emadi on LinkedIn: #healthiswealth #longevity #wellbeing

Tandem Mobi Insulin Pump Approved by FDA

Libre Life Diabetes News February 2024

Savvy Updates, 7/17/23: Tandem Mobi APPROVED, Insulet 510k Filing

Mengyu L. on LinkedIn: View my verified achievement from CDR.

Rosa Diaz-Perez, MD on LinkedIn: FDA clears Tandem Mobi durable

Tandem Mobi Becomes World's Smallest Insulin Pump with FDA

Insulin Pumps: Types and Advantages - GoodRx